David Lundrigan is a seasoned sales consultant specializing in cardiometabolic health, currently serving at Eli Lilly and Company since October 2023. Prior to this role, David held the position of Territory Business Manager at Ascensia Diabetes Care from October 2022 to November 2025, and served as Managing Director at Conmed - Hall - Linvatec from July 2016 to May 2023, where responsibility included the development of a new territory in Newfoundland and Labrador. David's career also includes experience as a Territory Account Manager at Bellwether Healthcare Solutions and as a Senior Pharmaceutical Sales Representative at Eli Lilly and Company from September 1999 to November 2014, focusing on market opportunities and customer relationships to drive sales growth. David holds a Bachelor of Applied Science in Mathematics from Memorial University of Newfoundland and Labrador.
This person is not in the org chart
This person is not in any teams
This person is not in any offices